Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares
November 11, 2025 20:40 ET | Source: Centessa Pharmaceuticals plc BOSTON and…
BPGbio Appoints John Dvor as Executive Vice President, Corporate Development
BOSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered,…
Vieworks Completes Major Expansion of Hwaseong Manufacturing Site, Doubling Production Capacity
Strategic Infrastructure Growth Positions Vieworks at the Forefront of Global Imaging Innovation…
The Sigourney Award-2025 Celebrates Four Recipients Honored for Creative Trailblazing Work Expanding Psychoanalytic Thought Globally
Interdisciplinary Work from Israel, Uruguay, and the United States Earns The Prestigious…
SMT Celebrates 20 Years of the Cocoon Occluder Journey, Transforming Lives in Congenital and Structural Heart Defects
Congenital Heart Disease (CHD) is one of the most common birth defects,…
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
November 10, 2025 21:56 ET | Source: Vor Biopharma BOSTON, Nov. 10,…
Canadian Red Cross sending emergency medical clinic to Jamaica
Humanitarian experts deploying to help people impacted by Hurricane Melissa November 10,…
TraceLink Customers Demonstrate Readiness as DSCSA Dispenser Deadline Arrives
TraceLink Continues to Set the Standard for United States Drug Supply Chain…
Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting
- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and…
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary…